RXDX
Charles Schwab’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-255,928
| Closed | -$27.5M | – | 3722 |
|
|
2023
Q1 | $27.5M | Sell |
255,928
-370
| -0.1% | -$39.7K | 0.01% | 1226 |
|
|
2022
Q4 | $28.2M | Buy |
256,298
+41,750
| +19% | +$4.59M | 0.01% | 1185 |
|
|
2022
Q3 | $12.7M | Buy |
214,548
+97,546
| +83% | +$5.76M | ﹤0.01% | 1683 |
|
|
2022
Q2 | $3.3M | Sell |
117,002
-3,749
| -3% | -$106K | ﹤0.01% | 2373 |
|
|
2022
Q1 | $4.56M | Buy |
120,751
+3,121
| +3% | +$118K | ﹤0.01% | 2321 |
|
|
2021
Q4 | $4.65M | Buy |
117,630
+41,919
| +55% | +$1.66M | ﹤0.01% | 2383 |
|
|
2021
Q3 | $1.8M | Buy |
75,711
+583
| +0.8% | +$13.8K | ﹤0.01% | 2720 |
|
|
2021
Q2 | $1.85M | Buy |
+75,128
| New | +$1.85M | ﹤0.01% | 2745 |
|